Calcium Channel Blocker versus Angiotensin II Receptor Blocker in Autosomal Dominant Polycystic Kidney Disease

Publisher： Karger

E-ISSN： 1660-2110|99|1|c18-c23

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.99, Iss.1, 2005-01, pp. : c18-c23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiotensin II receptor blocker prevents upper gastrointestinal bleeding in hypertensive patients with chronic kidney disease not on dialysis

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 7, 2015-07 ,pp. : 722-728

John Wiley & Sons Inc

Access to resources Recommend Favorite

Proteinuria as a Risk Marker for the Progression of Chronic Kidney Disease in Patients on Predialysis Care and the Role of Angiotensin-Converting Enzyme Inhibitor/Angiotensin II Receptor Blocker Treatment

By  

Nephron Clin Pract, Vol. 121, Iss. 1-2, 2012-10 ,pp. : c73-c82

Karger

Access to resources Recommend Favorite

Practical Genetics for Autosomal Dominant Polycystic Kidney Disease

By  

Nephron Clin Pract, Vol. 118, Iss. 1, 2010-11 ,pp. : c19-c30

Karger

Access to resources Recommend Favorite

Calcium channel blocker use and risk of Parkinson's disease: a meta‐analysis

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 24, Iss. 6, 2015-06 ,pp. : 559-566

John Wiley & Sons Inc

Access to resources Recommend Favorite

Retroperitoneoscopic Nephrectomy for Autosomal Dominant Polycystic Kidney Disease: Initial Experience

By  

Urologia Internationalis, Vol. 79, Iss. 2, 2007-09 ,pp. : 137-141

Karger

Access to resources Recommend Favorite